The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second interleukin-23p19 specific inhibitor approved for both major types of inflammatory ...

Atara Biotherapeutics said Thursday that the FDA has turned down its request to start selling its Ebvallo drug across state lines in a complete response letter.

The U.S. Food and Drug Administration on Thursday declined to approve Atara Biotherapeutics' cancer therapy, chemically ...

Omvoh's approval as a treatment for Crohn's disease was based on results from a study in which 53% of patients treated with the drug achieved clinical remission, and 46% of patients had visible ...

Eli Lilly said on Wednesday the U.S. health regulator has approved its drug to treat adults with moderate-to-severe Crohn's ...

The FDA has accepted Eisai and Biogen’s biologics license application for a monthly infusion of IV Leqembi to treat ...

The Centers for Medicare and Medicaid Services (CMS) has approved the implants for New Technology Add-on Payment (NTAP).

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor ...

The American Optometric Association (AOA) reports that while most Americans understand the importance of eye health, nearly ...

Former South African batting legend AB de Villiers had a special word of advice for Proteas top-run-getter in the ICC World Test Championship 2023-25 cycle, Da ...

Medically reviewed by Susan Bard, MD Intense pulsed light (IPL) therapy uses an intense beam of light to treat conditions ...

The expanded approval was based on data from a randomized, placebo-controlled, double-blind, parallel-group study (ClinicalTrials.gov Identifier: NCT05274269) that included 307 patients aged 6 ...